TIRZEPATIDA: foco no paciente e na saúde pública

In the debut episode of the ICTQ podcast "Acesso & Saúde" (Access & Health), journalist Egle Leonardi interviews nutritionist Gustavo Sá, founder of the Long Life SP Institute, for a conversation about obesity, diabetes, longevity, prevention, and access to innovative treatments. During the episode, the specialist discusses the role of compounded tinzepide in the treatment of obesity and type 2 diabetes, the challenges faced by patients due to the high cost of industrially manufactured medication, and the importance of individualized therapy in medical practice. The interview also discusses the economic and social impact of obesity, the need to expand access to effective medications, the role of compounding pharmacies in personalizing treatments, and the difference between treating the consequences of diseases and investing in prevention. "Acesso & Saúde" is an ICTQ podcast dedicated to discussing relevant topics in health, pharmacy, the pharmaceutical industry, regulation, innovation, and clinical practice. Guest: Nutritionist Dr. Gustavo Sá, founder of the Long Life SP Institute Presented by: Journalist Egle Leonardi Produced by: ICTQ